Paper · 9823339
A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer.
Boland CR and 10 others. Cancer Res, 1998. Cited by 3,572 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Papers, record 9823339. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9823339
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer.
- PubMed
- Publication types
- Consensus Statement, Consensus Development Conference, NIH, Journal Article, Review
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Colorectal Neoplasms | Major topic |
| Microsatellite Repeats | Major topic |
| Colorectal Neoplasms, Hereditary Nonpolyposis | |
| Forecasting | |
| Genetic Predisposition to Disease | |
| Humans | |
| Loss of Heterozygosity | |
| Prognosis | |
| United States |
Source PubMed
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References0
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
None in this release.
Cited by1,540
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3,572 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,983,841 | Panel-based next-generation sequencing with copy number variant detection pipeline could increase the detection rate of hereditary colorectal cancer syndrome compared with Sanger sequencing. | Hered Cancer Clin Pract | 2026 | https://conductscience.org/library/papers/42983841 | PubMed |
| 42,860,489 | Molecular characterization of colorectal cancer liver metastases with pure desmoplastic versus non-pure desmoplastic histopathological growth patterns using a targeted gene expression panel. | Clin Exp Metastasis | 2026 | https://conductscience.org/library/papers/42860489 | PubMed |
| 42,806,967 | Tumor-cell PD-L1 expression, mismatch repair status, and survival outcomes in colorectal carcinoma: a retrospective Pakistani cohort study. | Front Oncol | 2026 | https://conductscience.org/library/papers/42806967 | PubMed |
| 42,685,296 | Hunting for microsatellite instability in long-read data with Owl. | PLoS Comput Biol | 2026 | https://conductscience.org/library/papers/42685296 | PubMed |
| 42,491,298 | Application value of CT-based extracellular volume fraction in assessing microsatellite status in colorectal cancer. | Am J Transl Res | 2026 | https://conductscience.org/library/papers/42491298 | PubMed |
| 42,434,246 | Clinicopathological and molecular profiling of sporadic synchronous multiple primary colorectal cancers: focus on microsatellite instability status. | J Gastrointest Oncol | 2026 | https://conductscience.org/library/papers/42434246 | PubMed |
| 42,351,740 | Lynch Syndrome: An Update of Underlying Molecular Mechanisms, Phenotypes and Methods to Classify Variants of Uncertain Significance. | Biomedicines | 2026 | https://conductscience.org/library/papers/42351740 | PubMed |
| 42,294,596 | Evaluating statistical models for overdispersed multiomics data: a multiplex immunofluorescence case study. | Am J Epidemiol | 2026 | https://conductscience.org/library/papers/42294596 | PubMed |
| 42,289,019 | Paradoxical hyperprogressive disease in MSI-high intrahepatic cholangiocarcinoma treated with pembrolizumab. | Clin J Gastroenterol | 2026 | https://conductscience.org/library/papers/42289019 | PubMed |
| 42,279,419 | Redefining the Treatment Landscape of Advanced Endometrial Cancer in the Era of Immunotherapy and Precision Oncology. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/42279419 | PubMed |
1 to 10 of 1,540
See all 1,540 cited byGenes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| MBD4 | 8,930 | PubTator's text mining | https://conductscience.org/library/genes/8930 |
Source NCBI Gene
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/9823339
GET https://conductscience.org/api/papers/v1/9823339/cited_by?page=2